Delivery Order SPE2DB20D1004-SPE2DB22FF9T4

Award Date 7/27/22
Potential Completion Date 7/28/22
Potential Value $1.4K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Epinephrine 0.3 mg auto-injectors to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $1,837.44, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., valued at up to...
This federal contract award is for the delivery of epinephrine 0.3 mg auto-injector devices to the Defense Logistics Agency (DLA). The $3,655.71 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as the primary vehicle for the...
This federal contract award is for the delivery of epinephrine 0.15 mg auto-injectors to the Defense Logistics Agency (DLA). The contract, valued at $4,649.89, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and provides a comprehensive range of pharmaceutical products and...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Epinephrine 0.15 mg auto-injectors. The $6,416.12 firm fixed-price delivery order falls under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for the company to provide a comprehensive range of...
This federal contract award is for the delivery of Epinephrine 0.3 mg auto-injectors to the Defense Logistics Agency (DLA). The $1,794.36 Firm Fixed Price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of August 13, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award is for the delivery of epinephrine 0.3 mg auto-injectors to the Defense Logistics Agency (DLA). The contract, valued at $2,151.60, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. AmerisourceBergen is the subsidiary of the parent company, Cencora, Inc., which does business as AmerisourceBergen. The contract is a delivery order (SPE2DB23FN37R) under an Indefinite Delivery Contract (IDC) held by Cencora,...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of epinephrine 0.3 mg auto-injectors. The $2,619.46 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA) under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The IDC, which runs through November 2026, serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of Epinephrine 0.3 mg auto-injectors to the Defense Logistics Agency (DLA). The $1,794.36 contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products...
This federal contract award is for the delivery of Epinephrine 0.3 mg auto-injectors to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, under a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. The contract has a ceiling value of $5,454.52 and a completion date of September 7, 2023. This delivery order is not designated as a set-aside contract. Amerisourcebergen...
This federal contract award is for the delivery of epinephrine 0.3 mg auto-injectors, valued at $1,856.40. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB22FF9T4
    Delivery Order

This federal contract award is for the delivery of Epinephrine 0.3 mg auto-injectors to the Defense Logistics Agency (DLA) by AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,418.06 delivery order falls under a larger $999,999,999 Indefinite Delivery Contract (IDC) held by the parent company Cencora, Inc., which operates as AmerisourceBergen. This IDC serves as the primary vehicle for AmerisourceBergen to provide a wide range of pharmaceutical products and medical supplies to support military treatment facilities and veterans' healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen also holds a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 2/27/25, 1:38 PM